title: Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy.
authors.forename: Y
authors.initials: Y
authors.lastname: Akiyama
authors.forename: K
authors.initials: K
authors.lastname: Fujita
authors.forename: F
authors.initials: F
authors.lastname: Nagashima
authors.forename: W
authors.initials: W
authors.lastname: Yamamoto
authors.forename: H
authors.initials: H
authors.lastname: Endo
authors.forename: Y
authors.initials: Y
authors.lastname: Sunakawa
authors.forename: K
authors.initials: K
authors.lastname: Yamashita
authors.forename: H
authors.initials: H
authors.lastname: Ishida
authors.forename: K
authors.initials: K
authors.lastname: Mizuno
authors.forename: K
authors.initials: K
authors.lastname: Araki
authors.forename: W
authors.initials: W
authors.lastname: Ichikawa
authors.forename: T
authors.initials: T
authors.lastname: Miya
authors.forename: M
authors.initials: M
authors.lastname: Narabayashi
authors.forename: K
authors.initials: K
authors.lastname: Kawara
authors.forename: M
authors.initials: M
authors.lastname: Sugiyama
authors.forename: T
authors.initials: T
authors.lastname: Hirose
authors.forename: Y
authors.initials: Y
authors.lastname: Ando
authors.forename: Y
authors.initials: Y
authors.lastname: Sasaki
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D044466:Asian People; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D020022:Genetic Predisposition to Disease; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D000077146:Irinotecan; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011110:Polymorphism, Genetic; D000099148:UGT1A1 Enzyme
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D002166:Camptothecin; D014453:Glucuronosyltransferase; D000077146:Irinotecan; D000099148:UGT1A1 Enzyme